Skip to main content
Premium Trial:

Request an Annual Quote

The BioCommerce Week Index: Jun 2, 2005

BioCommerce Week's Index to the
Diversified Molecular Biology Tools Companies
Company
Ticker
Current Price
(May 31, 2005)
Last Price
(
May 24, 2005)
% Change
Agilent
A
24.01
23.89
0.50
Applied Biosystems
ABI
21.41
21.29
0.56
BD
BDX
57.45
58.27
-1.41
Beckman
BEC
70.06
68.08
2.91
Bio-Rad
BIO
53.88
52.55
2.53
Bruker
BRKR
4.20
3.96
6.06
GE
GE
36.48
37.07
-1.59
Harvard Bio
HBIO
3.22
3.02
6.62
Invitrogen
IVGN
79.34
80.83
-1.84
Molecular Devices
MDCC
19.32
19.04
1.47
PerkinElmer
PKI
19.13
19.20
-0.36
Sigma
SIAL
59.89
60.66
-1.27
Stratagene
STGN
8.57
8.59
-0.23
Thermo
TMO
26.32
26.66
-1.28
Waters
WAT
38.85
39.21
-0.92
Index Average
34.81
34.82
-0.4

Bruker, Harvard Bio Lead BCW Stocks for the Week

Bruker BioSciences and Harvard Bioscience were the top gainers in the BioCommerce Week Index for the five-day trading period ended Tuesday. The companies gained 6.06 percent and 6.62 percent, respectively, for the week. Bruker announced a couple of product launches, and Harvard Bio announced an upcoming conference call to discuss its strategic growth plans (look for an article in next week's issue of BCW).

Overall, the BCW Index closed down an unremarkable .04 percent for the week, beating out the Nasdaq Biotech Index, which closed down .7 percent at 678.17 for the same period. The broader Nasdaq closed up .3 percent at 2,068.22, and the Dow Jones Industrial Average closed down .3 percent at 10,467.48.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.